Buy & Sell Inovio Pharmaceuticals Inc (INO) – Inovio Pharmaceuticals Inc Price Today
Aura AI Summary
Key Stats
- $116.68MMarket Cap
- HealthSector
- -44.44%3M Drawdown
- $67.53MEnterprise Value
- -Dividend Yield
- 75% Buy | 25% SellTrading Activity
- 39 daysTypical Hold Time
Inovio Pharmaceuticals Inc (INO) is currently valued at a market capitalization of $116.68M, with an enterprise value of $67.53M. Over the past 52 weeks, Inovio Pharmaceuticals Inc has traded between a low of $1.05 and a high of $2.87, highlighting its annual price range. Over the past three months, Inovio Pharmaceuticals Inc has recorded a drawdown of -44.44%, reflecting recent price volatility. On average, investors hold Inovio Pharmaceuticals Inc for approximately 39 days, indicating typical investor behavior on the platform.
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Most Recent News
Geotab opens new engineering center in Detroit, creating 40 jobs to boost automotive innovation.
Geotab, a leader in connected transportation solutions, has opened a new engineering center in metro Detroit, Michigan. The facility will create up to 40 engineering jobs and serve as a hub for developing next-generation transportation technologies. ...
Biopesticides market grows on eco-friendly demand, tech advances, and rising organic food trends.
The global biopesticides market is expanding rapidly due to increasing demand for sustainable agriculture, driven by consumer health concerns and environmental regulations. Growth is supported by government incentives, rising organic food consumption...
Yusheng's Taocheche leads China's growing used-car market but faces losses amid trust-building costs.
Yusheng Holdings Ltd., operator of Taocheche, China's largest used-car platform, is preparing for an IPO as the country's used-car market expands, reaching 20.1 million transactions in 2025. Despite growing revenue and market share, Yusheng faces sig...